Cartalax is a synthetic bioregulatory tripeptide (composed of alanine, glutamic acid, and aspartic acid, or AED) studied for its potential to support joint health, cartilage repair, and anti-aging. Developed by the Khavinson group in Russia, it aims to influence gene expression and promote cellular regeneration.
Key Details & Research Focus
Mechanism: Its tiny molecular size allows it to penetrate cell nuclei and interact directly with DNA to modulate the transcription of genes associated with collagen synthesis.
Potential Applications: Explored for protecting chondrocytes (cartilage cells) from oxidative and inflammatory stress, potentially helping to reduce joint stiffness, improve mobility, and slow age-related tissue decline.
Safety & Regulation: While it has been sold in Eastern Europe and over the internet, it is still largely under-researched by Western standards. It is not a drug or dietary supplement approved by the FDA.
Cartalax
Important Notices:
You Must be a researcher and over 18 years old to purchase.
· This product is sold for scientific research purposes only.
· Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
· The quantity on the label refers to the total amount of product inside each vial.
· Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
· Vial appearance, label, seal and cap colors may vary from product photos.
